Intervention

losartan potassium

ClinicalTrials.gov intervention label

Clinical trials16

Recruiting0

Common conditions4

Lead sponsors shown5

Clinical trials

16 shown

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid TumorsNCT01234922 · 2011-02-01

Olmesartan Comparison to Losartan in Hypertensive SubjectsNCT00949884 · 2009-08-01

Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)NCT00756938 · 2009-03-01

LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)NCT00496834 · 2008-02-01

A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)NCT00447603 · 2007-05-24

The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)NCT00943852 · 2006-08-01

Antihypertensive Response to Losartan and Genetic PolymorphismsNCT00617877 · 2005-03-01

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed ConditionsNCT01216878 · 2004-09-01

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential HypertensionNCT00856271 · 2004-08-01

Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)NCT00953680 · 2004-04-01

Olmesartan Medoxomil Versus Losartan in Patients With HypertensionNCT00857285 · 2002-05-01

ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)NCT00140907 · 2000-03-14

MK0954 Versus Placebo for Treatment of Mild to Moderate HypertensionNCT00888355 · 1992-05-01

A Study to Investigate the Antihypertensive Efficacy of MK0954NCT00887250 · 1991-12-01

A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)NCT00886600 · 1991-05-01

A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)NCT00882440 · 1990-12-01

Common conditions

Hypertension13 Essential Hypertension2 High Blood Pressure1 Unspecified Adult Solid Tumor, Protocol Specific1

Leading sponsors

Organon and Co6 Merck Sharp & Dohme LLC5 Daiichi Sankyo3 Roxane Laboratories1 Wake Forest University Health Sciences1

Trial status mix

COMPLETED14

TERMINATED2

Phase mix

PHASE38

PHASE43

NA2

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.